Procyon (PCYN) 10-K 28 Sep 22 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Jun. 30, 2022	Sep. 19, 2022
Document Information [Line Items]
Entity Central Index Key	0000812306
Entity Registrant Name	PROCYON CORP
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	0-17449
Entity Incorporation, State or Country Code	CO
Entity Tax Identification Number	59-3280822
Entity Address, Address Line One	164 Douglas Rd
Entity Address, City or Town	Oldsmar
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34677
City Area Code	727
Local Phone Number	447-2998
Title of 12(g) Security	Common Stock
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float		$ 1,370,828
Entity Common Stock, Shares Outstanding		8,087,388
Auditor Name	Ferlita, Walsh, Gonzalez & Rodriguez, P.A.
Auditor Firm ID	232
Auditor Location	Tampa, FL

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Jun. 30, 2021
CURRENT ASSETS
Cash	$ 760,396	$ 1,226,522
Certificates of Deposit, plus accrued interest	281,105	280,438
Accounts Receivable, less allowance for doubtful accounts of $13,569 and $9,408 respectively	407,085	497,358
Inventories	761,651	591,058
Prepaid Expenses	374,817	276,251
TOTAL CURRENT ASSETS	2,585,054	2,871,627
PROPERTY AND EQUIPMENT, NET	153,702	109,275
OTHER ASSETS
Deposits	12,311	3,235
Inventories	182,224	263,280
Intangible Asset	17,000	17,000
ROU Assets - Operating Leases	706,155	882,344
Deferred Tax Asset, Net of Valuation Allowance of $31,960 and $0, respectively	146,051	120,430
Assets, Noncurrent, Excluding Property, Plant and Equipment	1,063,741	1,286,289
TOTAL ASSETS	3,802,497	4,267,191
CURRENT LIABILITIES
Accounts Payable	178,083	167,588
Accrued Expenses	302,601	413,977
Short Term Lease Liabilities	162,547	154,022
TOTAL CURRENT LIABILITIES	643,231	735,587
LONG TERM LIABILITIES
Long Term Lease Liabilities	491,312	653,860
TOTAL LONG TERM LIABILITIES	491,312	653,860
TOTAL LIABILITIES	1,134,543	1,389,447
COMMITMENTS AND CONTINGENCIES (NOTE G)
STOCKHOLDERS' EQUITY
Common Stock, no par value, 80,000,000 shares authorized; 8,087,388 and 8,087,388 shares issued and outstanding, respectively	4,444,766	4,444,766
Paid-in Capital	35,564	35,564
Accumulated Deficit	(1,939,236)	(1,729,446)
TOTAL STOCKHOLDERS' EQUITY	2,667,954	2,877,744
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	3,802,497	4,267,191
Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A Cumulative Convertible Preferred Stock, no par value; 4,000,000 shares authorized; 167,100 and 167,100 shares issued and outstanding, respectively.	$ 126,860	$ 126,860

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ / shares in Thousands	Jun. 30, 2022	Jun. 30, 2021
Accounts Receivable, allowance for doubtful accounts	$ 13,569	$ 9,408
Valuation allowance	$ 31,960	$ 0
Preferred stock, authorized (in shares)	496,000,000	496,000,000
Preferred stock, issued (in shares)	0	0
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, authorized (in shares)	80,000,000	80,000,000
Common stock, issued (in shares)	8,087,388	8,087,388
Common stock, outstanding (in shares)	8,087,388	8,087,388
Convertible Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,000,000	4,000,000
Preferred stock, issued (in shares)	167,100	167,100
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, outstanding (in shares)	167,100	167,100

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
NET SALES	$ 4,842,433	$ 4,719,672
COST OF SALES	1,356,612	1,330,979
GROSS PROFIT	3,485,821	3,388,693
OPERATING EXPENSES
Salaries and Benefits	2,012,430	1,831,804
Selling, General and Administrative	1,710,606	1,330,215
Operating Costs and Expenses, Total	3,723,036	3,162,019
(LOSS) / INCOME FROM OPERATIONS	(237,215)	226,674
OTHER INCOME
(Loss) on Disposal of Assets	0	304,887
Other Income / Gain on Extinguishment of Debt	0	203,172
Interest Income	1,804	1,232
Interest Expense	0	(2,172)
Nonoperating Income (Expense), Total	1,804	507,119
(LOSS) / INCOME BEFORE INCOME TAXES	(235,411)	733,793
INCOME TAX (EXPENSE) / BENEFIT	25,621	(39,444)
NET (LOSS) / INCOME	(209,790)	694,349
Dividend requirements on preferred stock	(16,710)	(16,710)
Basic net (loss) / income available to common shares	$ (226,500)	$ 677,639
Basic net (loss) / income per common share (in dollars per share)	$ (0.03)	$ 0.08
Weighted average number of common shares outstanding (in shares)	8,087,388	8,087,388
Diluted net (loss) / income per common share (in dollars per share)	$ (0.03)	$ 0.08
Weighted average number of common shares outstanding, diluted (in shares)	8,087,388	8,319,624

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member] Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings, Appropriated [Member]	Total
Balance (in shares) at Jun. 30, 2020	167,100	8,087,388
Balance at Jun. 30, 2020	$ 126,860	$ 4,444,766	$ 15,885	$ (2,423,795)	$ 2,163,716
Net Income (Loss)	0	0	0	219,096	219,096
Net (Loss) / Income	$ 0	$ 0	0	219,096	219,096
Balance (in shares) at Sep. 30, 2020	167,100	8,087,388
Balance at Sep. 30, 2020	$ 126,860	$ 4,444,766	15,885	(2,204,699)	2,382,812
Balance (in shares) at Jun. 30, 2020	167,100	8,087,388
Balance at Jun. 30, 2020	$ 126,860	$ 4,444,766	15,885	(2,423,795)	2,163,716
Net Income (Loss)					694,349
Net (Loss) / Income					694,349
Balance (in shares) at Jun. 30, 2021	167,100	8,087,388
Balance at Jun. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,729,446)	2,877,744
Balance (in shares) at Sep. 30, 2020	167,100	8,087,388
Balance at Sep. 30, 2020	$ 126,860	$ 4,444,766	15,885	(2,204,699)	2,382,812
Net Income (Loss)	0	0	0	74,313	74,313
Net (Loss) / Income	$ 0	$ 0	0	74,313	74,313
Balance (in shares) at Dec. 31, 2020	167,100	8,087,388
Balance at Dec. 31, 2020	$ 126,860	$ 4,444,766	15,885	(2,130,386)	2,457,125
Net Income (Loss)	0	0	0	21,714	21,714
Net (Loss) / Income	$ 0	$ 0	0	21,714	21,714
Balance (in shares) at Mar. 31, 2021	167,100	8,087,388
Balance at Mar. 31, 2021	$ 126,860	$ 4,444,766	15,885	(2,108,672)	2,478,839
Net Income (Loss)	0	0	0	379,226	379,226
Net (Loss) / Income	0	0	0	379,226	379,226
Stock Options Issued	$ 0	$ 0	19,679	0	19,679
Balance (in shares) at Jun. 30, 2021	167,100	8,087,388
Balance at Jun. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,729,446)	2,877,744
Net Income (Loss)	0	0	0	42,482	42,482
Net (Loss) / Income	$ 0	$ 0	0	42,482	42,482
Balance (in shares) at Sep. 30, 2021	167,100	8,087,388
Balance at Sep. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,686,964)	2,920,226
Balance (in shares) at Jun. 30, 2021	167,100	8,087,388
Balance at Jun. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,729,446)	2,877,744
Net Income (Loss)					(209,790)
Net (Loss) / Income					(209,790)
Balance (in shares) at Jun. 30, 2022	167,100	8,087,388
Balance at Jun. 30, 2022	$ 126,860	$ 4,444,766	35,564	(1,939,236)	2,667,954
Balance (in shares) at Sep. 30, 2021	167,100	8,087,388
Balance at Sep. 30, 2021	$ 126,860	$ 4,444,766	35,564	(1,686,964)	2,920,226
Net Income (Loss)	0	0	0	(67,562)	(67,562)
Net (Loss) / Income	$ 0	$ 0	0	(67,562)	(67,562)
Balance (in shares) at Dec. 31, 2021	167,100	8,087,388
Balance at Dec. 31, 2021	$ 126,860	$ 4,444,766	35,564	(1,754,526)	2,852,664
Net Income (Loss)	0	0	0	(105,348)	(105,348)
Net (Loss) / Income	$ 0	$ 0	0	(105,348)	(105,348)
Balance (in shares) at Mar. 31, 2022	167,100	8,087,388
Balance at Mar. 31, 2022	$ 126,860	$ 4,444,766	35,564	(1,859,874)	2,747,316
Net Income (Loss)	0	0	0	(79,362)	(79,362)
Net (Loss) / Income	$ 0	$ 0	0	(79,362)	(79,362)
Balance (in shares) at Jun. 30, 2022	167,100	8,087,388
Balance at Jun. 30, 2022	$ 126,860	$ 4,444,766	$ 35,564	$ (1,939,236)	$ 2,667,954

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net (Loss) / Income	$ (209,790)	$ 694,349
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	38,217	43,331
Increase in Allowance for Doubtful Accounts	4,161	0
Right of Use Asset Amortization	176,189	120,981
Accrued Interest on Certificate of Deposit	(667)	(306)
Deferred Income Taxes	(57,581)	184,063
Valuation Allowance	31,960	(144,619)
(Gain)/Loss on Sale of Assets	0	(304,887)
Gain on Extinguishment of Debt	0	(203,172)
Stock Based Compensation	0	19,679
Decrease (increase) in:
Accounts Receivable	86,112	(186,315)
Deposits	(9,076)	957
Inventory	(89,537)	(12,010)
Prepaid Expenses	(98,566)	(93,113)
Increase (decrease) in:
Accounts Payable	10,495	129
Accrued Interest Payable		(2,172)
Accrued Expenses	(111,376)	158,261
NET CASH (USED) / PROVIDED BY OPERATING ACTIVITIES	(229,459)	279,500
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of Certificate of Deposit		(125,000)
Redemption of Certificate of Deposit	0	0
Purchase of Property & Equipment	(82,644)	(65,166)
Proceeds on disposal of property and equipment	0	670,303
NET CASH (USED IN) / PROVIDED BY INVESTING ACTIVITIES	(82,644)	480,137
CASH FLOW FROM FINANCING ACTIVITIES
Payments on Operating Lease Liability	(154,023)	(198,949)
Proceeds from PPP Loan	0	0
NET CASH (USED IN) FINANCING ACTIVITIES	(154,023)	(198,949)
NET CHANGE IN CASH	(466,126)	560,688
CASH AT BEGINNING OF THE YEAR	1,226,522	665,834
CASH AT END OF THE YEAR	760,396	1,226,522
SUPPLEMENTAL DISCLOSURES
Interest Paid	0	0
Taxes Paid	$ 0	$ 0

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parentheticals)	12 Months Ended
	Jun. 30, 2022 USD ($)
Increase (Decrease) in Operating Lease Right-of-use Asset	$ 180,109.37
Increase (Decrease) in Operating Lease Liability	$ 180,109.37

Note A - Summary of Significant

Note A - Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Activity Procyon Corporation has two wholly-owned subsidiaries, AMERX Health Care Corp. (AMERX) and Sirius Medical Supply, Inc. (Sirius). AMERX manufactures and markets wound and skin care products primarily in the United States whereas Sirius previously marketed diabetic supplies primarily to Medicare patients in the United States. As previously reported, in July 2009, third July 31, 2009, no Principles of Consolidation The consolidated financial statements include the accounts of Procyon Corporation and its wholly-owned subsidiaries, AMERX and Sirius. All material inter-company accounts and transactions are eliminated. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents For the purpose of the Statements of Cash Flows, the Company considers cash-on-hand, demand deposits in banks and highly liquid investments purchased with an original maturity of three Concentration of Credit Risk The Company maintains its cash at various financial institutions. All accounts are fully insured by the Federal Deposit Insurance Corporation, up to $250,000 June 30, 2022 2021, Revenue Recognition The Company recognizes revenue in accordance with the Financial Accounting Standards Board's (FASB) release of Accounting Standards Update (ASU) 2014 09, 606 five 1 2 3 4 5 Accounts Receivable and Concentration of Credit Risk AMERX grants credit to customers, most of whom are national pharmaceutical distributors, drug stores nationwide and physicians. AMERX wholesales its products to national pharmaceutical distributors and drug stores at a sales term of 2/10, 2/10 The valuation of accounts receivable is based upon the credit-worthiness of customers as well as historical collection experience. Estimating the credit worthiness of customers and recoverability of customer accounts requires us to exercise considerable judgment. Allowances for doubtful accounts are recorded as a selling, general and administrative expense for estimated amounts expected to be uncollectible from third June 30, 2022 2021, Inventories Inventories are valued at the lower of average cost or net realized value determined by the first first not 12 Property and Equipment Property and equipment are stated at cost. Depreciation is computed on a straight-line basis over their estimated useful lives. Leased equipment is recorded at it’s fair market value at the beginning of the lease term and is depreciated over the life of the equipment. Depreciation on leased equipment is included in depreciation expense. Deferred Income Taxes Deferred income taxes are recognized for the expected tax consequences in future years for differences between the tax bases of assets and liabilities and their financial reporting amounts, based upon exacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. The Company accounts for income taxes under Topic 740 June 30, 2022. June 30, 2021. Fair Value of Financial Instruments The carrying value of cash, accounts receivable, prepaid expenses, deposits, inventory, accounts payable and accrued expenses approximate fair value. Considerable judgement is required in interpreting market data to develop the estimates of fair value, and accordingly, the estimates are not Shipping and Handling Costs Shipping and handling costs incurred were approximately $210,000 and $221,000 for the years ended June 30, 2022, 2021, Advertising and Marketing The Company records advertising and marketing expenses in the periods in which they are incurred. During the years ended June 30, 2022 2021, Stock Based Compensation In November 2020, 2020 “2020 The Company maintained the Procyon Corporation 2009 "2009 December 8, 2019. 2009 December 8, 2009. may 2009 The 2009 2009 2009 September 27, 2016, June 30, 2016. July 1, 2016 July 1, 2017. ten June 30, 2021, no 2009 2009 250,000 not 1933. Eligible participants under the 2009 may may Non-Qualified Stock Options granted under the 2009 not ten not 2009 not ten five not The 2020 422 not may The Board of Directors has authorized the issuance of 2,000,000 shares of Common Stock to underlie the granting of Awards under the 2020 2,000,000 2020 not 1933. no may 422 not ten five not first not Non-Qualified Stock Options are Options that is not not not ten not Effective June 30, 2021, 2021, July 1, 2020. September 24, 2021, June 30, 2021 ten .373 The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no not not Agreements to grant 40,000 25,000 September 27, 2016 August 23, 2017, June 30, 2016 June 30, 2017, 718 718" Effective as of June 30, 2021, 25,000 25,000 2021, July 1, 2020. June 30, 2021 ten .373 Additional information with respect to stock option activity is as follows: Number of Weighted Average Outstanding at June 30, 2020 65,000 $ 0.17 Granted 50,000 $ 0.37 Exercised - $ - Cancelled - $ - Outstanding at June 30, 2021 115,000 $ 0.26 Granted - $ - Exercised - $ - Cancelled - $ - Outstanding at June 30, 2022 115,000 $ 0.26 Options exercisable at June 30, 2021 115,000 $ 0.26 Options exercisable at June 30, 2022 115,000 $ 0.26 Net Income Per Common Share The Company computes net income per share in accordance with Accounting Standards Codification Topic 260 260 260 Subsequent Events We have evaluated subsequent events through September 27, 2022,

Note B - Inventories

Note B - Inventories	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE B - INVENTORIES Inventories consisted of the following: June 30, 2022 June 30, 2021 Finished Goods $ 759,118 $ 683,771 Raw Materials 184,757 170,567 $ 943,875 $ 854,338 At June 30, 2022 2021, not one

Note C - Property and Equipment

Note C - Property and Equipment	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE C - PROPERTY AND EQUIPMENT Property and equipment consisted of the following: As of June 30, 2022 Owned Capitalized Leases Total Office Equipment 224,635 $ 0 $ 224,635 Furniture and Fixtures 95,038 0 95,038 Software 26,021 0 26,021 Leasehold improvements 35,907 0 35,907 Production Equipment 26,752 0 26,752 Building 18,392 0 18,392 426,745 0 426,745 Less accumulated depreciation (273,043 ) 0 (273,043 ) $ 153,702 $ 0 $ 153,702 Depreciation expense was $38,217 for the year ended June 30, 2022. As of June 30, 2021 Owned Capitalized Leases Total Office Equipment $ 223,018 $ 0 $ 223,018 Furniture and Fixtures 45,082 0 45,082 Software 26,021 0 26,021 Leasehold Improvements 26,301 0 26,301 Production Equipment 26,249 0 26,249 Building 18,392 0 18,392 365,063 0 365,063 Less accumulated depreciation (255,788 ) 0 (255,788 ) $ 109,275 $ 0 $ 109,275 Depreciation expense was $43,331 for the year ended June 30, 2021.

Note D - Intangible Assets

Note D - Intangible Assets	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE D - INTANGIBLE ASSETS On June 30, 2017, not 350,

Note E - Accrued Expenses

Note E - Accrued Expenses	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	NOTE E - ACCRUED EXPENSES Accrued expenses consist of the following at June 30, 2022 2021. 2022 2021 Accrued Payroll $ 151,341 $ 131,187 Accrued Paid Time Off 41,837 29,899 Accrued Professional Fees 53,681 50,916 Accrued Incentive Plan 10,789 153,494 Accrued Lease Liabiity 40,439 38,620 Other 4,514 9,861 Total $ 302,601 $ 413,977

Note F - Line of Credit

Note F - Line of Credit	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE F - LINE OF CREDIT In fiscal 2019, June 30, 2021 June 30, 2021, not A new line of credit was procured in June 2021, June 30, 2023. June 30, 2022, Interest expense for the years ended June 30, 2022 2021 The line of credit is guaranteed by Justice W. Anderson, President and Chief Executive Officer.

Note G - Paycheck Protection Pr

Note G - Paycheck Protection Program Loan	12 Months Ended
	Jun. 30, 2022
PPP Loan [Member]
Notes to Financial Statements
Unusual or Infrequent Items, or Both, Disclosure [Text Block]	NOTE G - PAYCHECK PROTECTION PROGRAM LOAN The Company applied for a loan with the Small Business Administration (the "SBA") Paycheck Protection Program ("PPP") of the Coronavirus Aid, Relief and Economic Security Act of 2020 April 13, 2020. The Loan, which is evidenced by a promissory note (the "Note"), has a two April 13, 2022, 1.00% seven not may The Loan may eight April 13, 2020. The loan was forgiven in full in May 2021.

Note H - Commitments and Contin

Note H - Commitments and Contingencies	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE H - COMMITMENTS AND CONTINGENCIES The Company leased warehouse office space under operating leases expiring through year 2021. June 30, 2021 June 30, 2023 $ 181,326 2024 184,805 2025 188,353 2026 141,062 $ 695,546

Note I - Stockholders' Equity

Note I - Stockholders' Equity	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE I - STOCKHOLDERS EQUITY During January 1995, $.10 June 30, 2022, June 30, 2022. The preferred stockholders have the right to convert each share of Series A Cumulative Convertible Preferred Stock into one share of the Company's common stock at any time without additional consideration. Each share of Series A Cumulative Convertible Preferred Stock is subject to mandatory conversion into one share of common stock of the Company, effective as of the close of a public offering of the Company's common stock provided, however, that the offering must provide a minimum of $1 million in gross proceeds to the Company and the initial offering price of such common stock must be at least $1 per share. In addition to the rights described above, the holders of the Series A Cumulative Convertible Preferred Stock have voting rights equal to the common stockholders based upon the number of shares of common stock into which the Series A Cumulative Convertible Preferred Stock is convertible. The Company is obligated to reserve an adequate number of shares of its common stock to satisfy the conversion of all of the outstanding Series A Cumulative Convertible Preferred stock. Share-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest. As share-based compensation expense recognized in the statement of operations is based on awards ultimately expected to vest, it can be reduced for estimated forfeitures. The ASC topic Stock Compensation requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The share based compensation charged against income for the periods ended June 30, 2022 2021 The Black-Scholes option-pricing model, which values options based on the stock price at grant date, the expected life of the options, the estimated volatility of the stock and the risk free interest rate over the life of the option. The assumption used in the Black-Scholes model were as follows for the stock options granted for the year ended June 30, 2021. Stock Price at Date of Grant $ 0.37 Risk-free interest rate 1.41 % Expected volatility of common stock 183.81 % Dividend yield 0 % Expected life of options (in years) 10

Note J - Earnings Per Share

Note J - Earnings Per Share	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE J - EARNINGS PER SHARE As required by Accounting Standards Codification Topic 260 260" Years Ended June 30, 2022 2021 Numerator: Net (Loss) Income $ (209,790 ) $ 694,349 Adjustment for basic earnings per share: Dividend requirements on preferred stock (16,710 ) (16,710 ) Numerator for basic earnings per share- Net income available to common stockholders $ (226,500 ) $ 677,639 Effect of dilutive securities: Numerator for diluted earnings per share-Net income available to common stockholder $ (226,500 ) $ 677,639 Denominator: Denominator for basic earnings per share-Weighted-average common shares 8,087,388 8,087,388 Effect of dilutive securities:Stock options 0 65,136 Weighted-average Dilutive potential common shares 0 167,100 Denominator for dilutive earnings per share-Adjusted weighted-average shares and assumed conversions 8,087,388 8,319,624 Basic Net Income per share $ (0.03 ) $ 0.08 Diluted Net Income per share $ (0.03 ) $ 0.08

Note K - Income Taxes and Avail

Note K - Income Taxes and Available Carryforward	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE K - INCOME TAXES AND AVAILABLE CARRYFORWARD As of June 30, 2022, December 31, 2020 2035 December 31, 2020, 80% 382 The components of the provision for income taxes expenses are attributable to continuing operations as follows: Year ended June 30, 2022 Year ended June 30, 2021 Current Federal $ - $ - State - - - - Deferred Federal $ 21,229 $ (32,681 ) State 4,392 (6,763 ) $ 25,621 $ (39,444 ) Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows: Non-Current Deferred tax assets: NOL and contribution carryforwards $ 208,277 Share based payments 4,988 Lease Liabilities - operating leases 164,727 Accrued compensated absences 10,604 Accrued bonus 2,734 Allowance for doubtful accounts 3,439 394,769 Deferred tax (liabilities): Right of use assets - operating leases (177,981 ) Excess of tax over book depreciation (38,777 ) Total deferred tax (liabilities) (216,758 ) Net deferred tax asset (liability) 178,011 Valuation Allowance (31,960 ) Net deferred tax asset $ 146,051 The change in the valuation allowance is as follows: June 30, 2022 $ (31,960 ) June 30, 2021 - $ (31,960 ) Income taxes for the years ended June 30, 2022 2021 2022 2021 Expected benefit (provision) at US statutory rate $ 49,436 $ (154,097 ) State income tax net of federal benefit (provision) 10,229 (31,883 ) Nondeductible expense (689 ) (3,450 ) Non Taxable Income - 51,494 Change in estimates of losses carryforward (1,395 ) (46,127 ) Change in valuation allowance (31,960 ) 144,619 Income tax benefit (expense) $ 25,621 $ (39,444 ) The earliest tax year still subject to examination by taxing jurisdictions is fiscal year June 30, 2019. The Company performed a review of its uncertain tax positions in accordance with Accounting Standards Codification ASC 740 10 not During the year ended June 30, 2020, 19 June 30, 2020, 19 May 2021. 2021, 116 260 Dec. 27, 2020, not not no

Note L - Concentration of Suppl

Note L - Concentration of Supply Risk	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE L - CONCENTRATION OF SUPPLY RISK The Company's manufacturing and packaging activities are performed at a production facility owned and operated by a non-affiliated pharmaceutical manufacturer. At the present time, the manufacturer is the major source of the Company’s wound care products. The sudden loss or failure of this manufacturer could significantly impair AMERX’s ability to fulfill customer orders on a short-term basis and therefore, could materially and adversely affect the Company’s operations. However, the Company has maintained a long-term relationship with this manufacturer and does not There were no June 30, 2022 2021,

Note M - Major Customer

Note M - Major Customer	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Major Customer Disclosure [Text Block]	NOTE M - MAJOR CUSTOMER During the year ended June 30, 2021 10% 2022 10%

Note N - Research and Developme

Note N - Research and Development	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE N - RESEARCH AND DEVELOPMENT AMERX incurred $30,000 and $30,900 during the years ended June 30, 2022 2021,

Note O - Pandemic Health Issue

Note O - Pandemic Health Issue	12 Months Ended
	Jun. 30, 2022
COVID 19 Health Issue [Member]
Notes to Financial Statements
Unusual or Infrequent Items, or Both, Disclosure [Text Block]	NOTE O - PANDEMIC HEALTH ISSUE At the time of release of these financial statements, the United States continues to experience a National Emergency related to persistent health issues caused by the COVID- 19

Note P - Right-of-use Assets an

Note P - Right-of-use Assets and Lease Liabilities	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	NOTE P - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES Operating Leases In June 2015, one not no 842, 63 September 2020. September 30, 2020. In February 2018, first three 12 8 4 12 842, 39 In August 2020, not 842, 63 In January 2021, first four 5th no not 842, In January 2021, first four 5th no not 842, 64 The following is information related to the Company’s right-of-use assets and liabilities for its operating leases: ROU assets - operating leases obtained in exchange for lease liabilities - operating leases $ 973,081 Amortization of ROU assets since lease inception (266,926 ) ROU assets - operating leases at June 30, 2022 $ 706,155 Lease liabilities - operating leases on adoption date $ 973,081 Payments on lease liabilities (319,222 ) Lease liabilities - operating leases on June 30, 2022 653,859 Lease liabilities - operating leases due in the 12 months ending June 30, 2022 162,547 Lease liabilities - operating leases due after June 30, 2022 $ 491,312 Variable lease expense was $208,467 and $133,531 for the years ended June 30, 2022 2021, Weighted average remaining lease term was 3.74 years and weighted average discount rate was 3.29% at June 30, 2022.

Note Q - Recent Accounting Pron

Note Q - Recent Accounting Pronouncements	12 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]	NOTE Q - RECENT ACCOUNTING PRONOUNCEMENTS In June 2016, No. 2016 13, 326 {44ASU 2016 13" 2016 13 December 15, 2020 October 2019, December 15, 2022, July 1, 2023.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of Procyon Corporation and its wholly-owned subsidiaries, AMERX and Sirius. All material inter-company accounts and transactions are eliminated.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents For the purpose of the Statements of Cash Flows, the Company considers cash-on-hand, demand deposits in banks and highly liquid investments purchased with an original maturity of three
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk The Company maintains its cash at various financial institutions. All accounts are fully insured by the Federal Deposit Insurance Corporation, up to $250,000 June 30, 2022 2021,
Revenue [Policy Text Block]	Revenue Recognition The Company recognizes revenue in accordance with the Financial Accounting Standards Board's (FASB) release of Accounting Standards Update (ASU) 2014 09, 606 five 1 2 3 4 5
Accounts Receivable [Policy Text Block]	Accounts Receivable and Concentration of Credit Risk AMERX grants credit to customers, most of whom are national pharmaceutical distributors, drug stores nationwide and physicians. AMERX wholesales its products to national pharmaceutical distributors and drug stores at a sales term of 2/10, 2/10 The valuation of accounts receivable is based upon the credit-worthiness of customers as well as historical collection experience. Estimating the credit worthiness of customers and recoverability of customer accounts requires us to exercise considerable judgment. Allowances for doubtful accounts are recorded as a selling, general and administrative expense for estimated amounts expected to be uncollectible from third June 30, 2022 2021,
Inventory, Policy [Policy Text Block]	Inventories Inventories are valued at the lower of average cost or net realized value determined by the first first not 12
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost. Depreciation is computed on a straight-line basis over their estimated useful lives. Leased equipment is recorded at it’s fair market value at the beginning of the lease term and is depreciated over the life of the equipment. Depreciation on leased equipment is included in depreciation expense.
Income Tax, Policy [Policy Text Block]	Deferred Income Taxes Deferred income taxes are recognized for the expected tax consequences in future years for differences between the tax bases of assets and liabilities and their financial reporting amounts, based upon exacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. The Company accounts for income taxes under Topic 740 June 30, 2022. June 30, 2021.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The carrying value of cash, accounts receivable, prepaid expenses, deposits, inventory, accounts payable and accrued expenses approximate fair value. Considerable judgement is required in interpreting market data to develop the estimates of fair value, and accordingly, the estimates are not
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling Costs Shipping and handling costs incurred were approximately $210,000 and $221,000 for the years ended June 30, 2022, 2021,
Advertising Cost [Policy Text Block]	Advertising and Marketing The Company records advertising and marketing expenses in the periods in which they are incurred. During the years ended June 30, 2022 2021,
Share-Based Payment Arrangement [Policy Text Block]	Stock Based Compensation In November 2020, 2020 “2020 The Company maintained the Procyon Corporation 2009 "2009 December 8, 2019. 2009 December 8, 2009. may 2009 The 2009 2009 2009 September 27, 2016, June 30, 2016. July 1, 2016 July 1, 2017. ten June 30, 2021, no 2009 2009 250,000 not 1933. Eligible participants under the 2009 may may Non-Qualified Stock Options granted under the 2009 not ten not 2009 not ten five not The 2020 422 not may The Board of Directors has authorized the issuance of 2,000,000 shares of Common Stock to underlie the granting of Awards under the 2020 2,000,000 2020 not 1933. no may 422 not ten five not first not Non-Qualified Stock Options are Options that is not not not ten not Effective June 30, 2021, 2021, July 1, 2020. September 24, 2021, June 30, 2021 ten .373 The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no not not Agreements to grant 40,000 25,000 September 27, 2016 August 23, 2017, June 30, 2016 June 30, 2017, 718 718" Effective as of June 30, 2021, 25,000 25,000 2021, July 1, 2020. June 30, 2021 ten .373 Additional information with respect to stock option activity is as follows: Number of Weighted Average Outstanding at June 30, 2020 65,000 $ 0.17 Granted 50,000 $ 0.37 Exercised - $ - Cancelled - $ - Outstanding at June 30, 2021 115,000 $ 0.26 Granted - $ - Exercised - $ - Cancelled - $ - Outstanding at June 30, 2022 115,000 $ 0.26 Options exercisable at June 30, 2021 115,000 $ 0.26 Options exercisable at June 30, 2022 115,000 $ 0.26
Earnings Per Share, Policy [Policy Text Block]	Net Income Per Common Share The Company computes net income per share in accordance with Accounting Standards Codification Topic 260 260 260
Subsequent Events, Policy [Policy Text Block]	Subsequent Events We have evaluated subsequent events through September 27, 2022,

Note A - Summary of Significa_2

Note A - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Weighted Average Outstanding at June 30, 2020 65,000 $ 0.17 Granted 50,000 $ 0.37 Exercised - $ - Cancelled - $ - Outstanding at June 30, 2021 115,000 $ 0.26 Granted - $ - Exercised - $ - Cancelled - $ - Outstanding at June 30, 2022 115,000 $ 0.26 Options exercisable at June 30, 2021 115,000 $ 0.26 Options exercisable at June 30, 2022 115,000 $ 0.26

Note B - Inventories (Tables)

Note B - Inventories (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Inventory, Current and Noncurrent [Table Text Block]	June 30, 2022 June 30, 2021 Finished Goods $ 759,118 $ 683,771 Raw Materials 184,757 170,567 $ 943,875 $ 854,338

Note C - Property and Equipme_2

Note C - Property and Equipment (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of June 30, 2022 Owned Capitalized Leases Total Office Equipment 224,635 $ 0 $ 224,635 Furniture and Fixtures 95,038 0 95,038 Software 26,021 0 26,021 Leasehold improvements 35,907 0 35,907 Production Equipment 26,752 0 26,752 Building 18,392 0 18,392 426,745 0 426,745 Less accumulated depreciation (273,043 ) 0 (273,043 ) $ 153,702 $ 0 $ 153,702 As of June 30, 2021 Owned Capitalized Leases Total Office Equipment $ 223,018 $ 0 $ 223,018 Furniture and Fixtures 45,082 0 45,082 Software 26,021 0 26,021 Leasehold Improvements 26,301 0 26,301 Production Equipment 26,249 0 26,249 Building 18,392 0 18,392 365,063 0 365,063 Less accumulated depreciation (255,788 ) 0 (255,788 ) $ 109,275 $ 0 $ 109,275

Note E - Accrued Expenses (Tabl

Note E - Accrued Expenses (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	2022 2021 Accrued Payroll $ 151,341 $ 131,187 Accrued Paid Time Off 41,837 29,899 Accrued Professional Fees 53,681 50,916 Accrued Incentive Plan 10,789 153,494 Accrued Lease Liabiity 40,439 38,620 Other 4,514 9,861 Total $ 302,601 $ 413,977

Note H - Commitments and Cont_2

Note H - Commitments and Contingencies (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	2023 $ 181,326 2024 184,805 2025 188,353 2026 141,062 $ 695,546

Note I - Stockholders' Equity (

Note I - Stockholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Stock Price at Date of Grant $ 0.37 Risk-free interest rate 1.41 % Expected volatility of common stock 183.81 % Dividend yield 0 % Expected life of options (in years) 10

Note J - Earnings Per Share (Ta

Note J - Earnings Per Share (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Years Ended June 30, 2022 2021 Numerator: Net (Loss) Income $ (209,790 ) $ 694,349 Adjustment for basic earnings per share: Dividend requirements on preferred stock (16,710 ) (16,710 ) Numerator for basic earnings per share- Net income available to common stockholders $ (226,500 ) $ 677,639 Effect of dilutive securities: Numerator for diluted earnings per share-Net income available to common stockholder $ (226,500 ) $ 677,639 Denominator: Denominator for basic earnings per share-Weighted-average common shares 8,087,388 8,087,388 Effect of dilutive securities:Stock options 0 65,136 Weighted-average Dilutive potential common shares 0 167,100 Denominator for dilutive earnings per share-Adjusted weighted-average shares and assumed conversions 8,087,388 8,319,624 Basic Net Income per share $ (0.03 ) $ 0.08 Diluted Net Income per share $ (0.03 ) $ 0.08

Note K - Income Taxes and Ava_2

Note K - Income Taxes and Available Carryforward (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Year ended June 30, 2022 Year ended June 30, 2021 Current Federal $ - $ - State - - - - Deferred Federal $ 21,229 $ (32,681 ) State 4,392 (6,763 ) $ 25,621 $ (39,444 )
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Non-Current Deferred tax assets: NOL and contribution carryforwards $ 208,277 Share based payments 4,988 Lease Liabilities - operating leases 164,727 Accrued compensated absences 10,604 Accrued bonus 2,734 Allowance for doubtful accounts 3,439 394,769 Deferred tax (liabilities): Right of use assets - operating leases (177,981 ) Excess of tax over book depreciation (38,777 ) Total deferred tax (liabilities) (216,758 ) Net deferred tax asset (liability) 178,011 Valuation Allowance (31,960 ) Net deferred tax asset $ 146,051 The change in the valuation allowance is as follows: June 30, 2022 $ (31,960 ) June 30, 2021 - $ (31,960 )
Comprehensive Income (Loss) [Table Text Block]	2022 2021 Expected benefit (provision) at US statutory rate $ 49,436 $ (154,097 ) State income tax net of federal benefit (provision) 10,229 (31,883 ) Nondeductible expense (689 ) (3,450 ) Non Taxable Income - 51,494 Change in estimates of losses carryforward (1,395 ) (46,127 ) Change in valuation allowance (31,960 ) 144,619 Income tax benefit (expense) $ 25,621 $ (39,444 )

Note P - Right-of-use Assets _2

Note P - Right-of-use Assets and Lease Liabilities (Tables)	12 Months Ended
	Jun. 30, 2022
Notes Tables
Lessee, Operating Lease, Right-of-Use Assets and Liabilities [Table Text Block]	ROU assets - operating leases obtained in exchange for lease liabilities - operating leases $ 973,081 Amortization of ROU assets since lease inception (266,926 ) ROU assets - operating leases at June 30, 2022 $ 706,155 Lease liabilities - operating leases on adoption date $ 973,081 Payments on lease liabilities (319,222 ) Lease liabilities - operating leases on June 30, 2022 653,859 Lease liabilities - operating leases due in the 12 months ending June 30, 2022 162,547 Lease liabilities - operating leases due after June 30, 2022 $ 491,312

Note A - Summary of Significa_3

Note A - Summary of Significant Accounting Policies (Details Textual) - USD ($)					12 Months Ended
	Jun. 30, 2021	Jul. 01, 2017	Sep. 27, 2016	Jul. 01, 2016	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2019
Number of Wholly Owned Subsidiaries					2
Cash, Uninsured Amount	$ 30				$ 52,539	$ 30
Percentage of Discount on Bill Payment Within Ten Days to Pharmaceutical Distributors and Drug Stores					2%
Term of Sale for Pharmaceutical Distributors and Drug Stores (Day)					30 days
Percentage of Discount on Bill Payment Within Ten Days to Physicians					2%
Standard Payment Term to Physicians (Day)					30 days
Accounts Receivable, Allowance for Credit Loss, Ending Balance	9,400				$ 13,600	9,400
Deferred Tax Assets, Valuation Allowance	$ 0				$ 31,960	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)					0	50,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)					$ 0	$ 0.37
The 2009 Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)					0
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							1,000,000
The 2009 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							500,000
The 2009 Option Plan [Member] | Incentive Stock Options [Member] | Ten Percent Owners [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent							110%
The 2009 Option Plan [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							500,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)			250,000
The 2009 Option Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Justice Anderson [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)		25,000		40,000
The 2020 Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)					2,000,000
The 2020 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Aggregate Fair Market Value Per First-time Participant					$ 100,000
The 2020 Option Plan [Member] | Incentive Stock Options [Member] | Ten Percent Owners [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent					110%
The 2020 Option Plan [Member] | Non-Qualified Stock Options [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	25,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)	$ 0.373
The 2020 Option Plan [Member] | Non-Qualified Stock Options [Member] | Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	25,000
The 2020 Option Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Per Award (in shares)							1
Selling, General and Administrative Expenses [Member]
Shipping and Handling Expense, Total					$ 210,000	$ 221,000
Marketing and Advertising Expense, Total					$ 473,000	$ 240,000
Maximum [Member]
Accounts Receivable, Allowance, Percentage	3%				2%	3%
Maximum [Member] | The 2009 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)							10 years
Maximum [Member] | The 2009 Option Plan [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)							10 years
Maximum [Member] | The 2020 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)					10 years
Maximum [Member] | The 2020 Option Plan [Member] | Incentive Stock Options [Member] | Ten Percent Owners [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)					5 years
Maximum [Member] | The 2020 Option Plan [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)					10 years
Minimum [Member] | The 2009 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent							100%
Minimum [Member] | The 2009 Option Plan [Member] | Incentive Stock Options [Member] | Ten Percent Owners [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)							5 years
Minimum [Member] | The 2009 Option Plan [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent							100%
Minimum [Member] | The 2020 Option Plan [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent					100%
Minimum [Member] | The 2020 Option Plan [Member] | Non-Qualified Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent					100%

Note A - Summary of Significa_4

Note A - Summary of Significant Accounting Policies - Stock Option Activity (Details)	12 Months Ended
	Jun. 30, 2022 $ / shares shares	Jun. 30, 2021 $ / shares shares
Outstanding at June 30, 2020 (in shares) | shares	115,000	65,000
Outstanding at June 30, 2020 (in dollars per share) | $ / shares	$ 0.26	$ 0.17
Granted (in shares) | shares	0	50,000
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 0	$ 0.37
Exercised (in shares) | shares	0	0
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 0	$ 0
Cancelled (in shares) | shares	0	0
Cancelled, weighted average exercise price (in dollars per share) | $ / shares	$ 0	$ 0
Outstanding at June 30, 2021 (in shares) | shares	115,000	115,000
Outstanding at June 30, 2021 (in dollars per share) | $ / shares	$ 0.26	$ 0.26
Options exercisable (in shares) | shares	115,000	115,000
Options exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 0.26	$ 0.26

Note B - Inventories (Details T

Note B - Inventories (Details Textual) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Inventory, Noncurrent, Total	$ 182,224	$ 263,280

Note B - Inventories - Inventor

Note B - Inventories - Inventories (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Finished Goods	$ 759,118	$ 683,771
Raw Materials	184,757	170,567
Inventory, Gross, Total	$ 943,875	$ 854,338

Note C - Property and Equipme_3

Note C - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Depreciation, Total	$ 38,217	$ 43,331

Note C - Property and Equipme_4

Note C - Property and Equipment - Property and Equipment (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Property and equipment, owned	$ 426,745	$ 365,063
Property and equipment, capitalized leases	0	0
Property and equipment, gross	426,745	365,063
Less accumulated depreciation, owned	(273,043)	(255,788)
Less accumulated depreciation, capitalized leases	0	0
Less accumulated depreciation	(273,043)	(255,788)
Property and equipment, net, owned	153,702	109,275
Property and equipment, net, capitalized leases	0	0
Property and equipment, net	153,702	109,275
Office Equipment [Member]
Property and equipment, owned	224,635	223,018
Property and equipment, capitalized leases	0	0
Property and equipment, gross	224,635	223,018
Furniture and Fixtures [Member]
Property and equipment, owned	95,038	45,082
Property and equipment, gross	95,038	45,082
Software [Member]
Property and equipment, owned	26,021	26,021
Property and equipment, gross	26,021	26,021
Leasehold Improvements [Member]
Property and equipment, owned	35,907	26,301
Property and equipment, gross	35,907	26,301
Production Equipment [Member]
Property and equipment, owned	26,752	26,249
Property and equipment, gross	26,752	26,249
Building [Member]
Property and equipment, owned	18,392	18,392
Property and equipment, gross	$ 18,392	$ 18,392

Note D - Intangible Assets (Det

Note D - Intangible Assets (Details Textual)	12 Months Ended
	Jun. 30, 2017 USD ($)
Formulation of Care Lotion [Member]
Finite-lived Intangible Assets Acquired	$ 17,000

Note E - Accrued Expenses - Acc

Note E - Accrued Expenses - Accrued Expenses (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Accrued Payroll	$ 151,341	$ 131,187
Accrued Paid Time Off	41,837	29,899
Accrued Professional Fees	53,681	50,916
Accrued Incentive Plan	10,789	153,494
Accrued Lease Liabiity	40,439	38,620
Other	4,514	9,861
Total	$ 302,601	$ 413,977

Note F - Line of Credit (Detail

Note F - Line of Credit (Details Textual) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2019
Line of Credit Facility, Maximum Borrowing Capacity		$ 250,000	$ 250,000
Long-Term Line of Credit, Total	$ 0	0
Interest Expense, Debt, Total	$ 0	$ 0

Note G - Paycheck Protection _2

Note G - Paycheck Protection Program Loan (Details Textual) - USD ($)	Jun. 30, 2020	Apr. 13, 2020
Paycheck Protection Program CARES Act [Member]
Notes Payable, Total	$ 201,000	$ 201,000

Note H - Commitments and Cont_3

Note H - Commitments and Contingencies (Details Textual)	12 Months Ended
	Jun. 30, 2022 USD ($)
Operating Lease, Expense	$ 31,091

Note H - Commitments and Cont_4

Note H - Commitments and Contingencies - Minimum Lease Payments (Details) - Lease for Office Space, Warehouse Space and Certain Equipment [Member]	Jun. 30, 2022 USD ($)
2023	$ 181,326
2024	184,805
2025	188,353
2026	141,062
Lessee, Operating Lease, Liability, to be Paid, Total	$ 695,546

Note I - Stockholders' Equity_2

Note I - Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 1995	Jun. 30, 2022	Jun. 30, 2021
Preferred Stock, Shares Authorized (in shares)		496,000,000	496,000,000
Share Price (in dollars per share)		$ 0.37
Share-Based Payment Arrangement, Expense		$ 0	$ 19,679
Minimum [Member]
Share Price (in dollars per share)		$ 1
Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)	4,000,000	4,000,000	4,000,000
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in dollars per share)	$ 0.10
Dividends, Preferred Stock, Total		$ 0
Preferred Stock, Amount of Preferred Dividends in Arrears		$ 421,226
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in dollars per share)		$ 2.52
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)		1
Proceeds From Public Offering Required for Mandatory Conversion		$ 1,000,000

Note I - Stockholders' Equity -

Note I - Stockholders' Equity - Summary of Stock Option Valuation Assumptions (Details)	12 Months Ended
	Jun. 30, 2022 $ / shares
Stock Price at Date of Grant (in dollars per share)	$ 0.37
Risk-free interest rate	1.41%
Expected volatility of common stock	183.81%
Dividend yield	0%
Expected life of options (Year)	10 years

Note J - Earnings Per Share - E

Note J - Earnings Per Share - Earnings Per Share (Details) - USD ($)	3 Months Ended								12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2022	Jun. 30, 2021
Net Income (Loss)	$ (79,362)	$ (105,348)	$ (67,562)	$ 42,482	$ 379,226	$ 21,714	$ 74,313	$ 219,096	$ (209,790)	$ 694,349
Dividend requirements on preferred stock									(16,710)	(16,710)
Numerator for basic earnings per share- Net income available to common stockholders									(226,500)	677,639
Numerator for diluted earnings per share-Net income available to common stockholder									$ (226,500)	$ 677,639
Weighted average number of common shares outstanding (in shares)									8,087,388	8,087,388
Effect of dilutive securities:Stock options (in shares)									0	65,136
Weighted-average Dilutive potential common shares (in shares)									0	167,100
Denominator for dilutive earnings per share-Adjusted weighted-average shares and assumed conversions (in shares)									8,087,388	8,319,624
Basic net (loss) / income per common share (in dollars per share)									$ (0.03)	$ 0.08
Diluted net (loss) / income per common share (in dollars per share)									$ (0.03)	$ 0.08

Note K - Income Taxes and Ava_3

Note K - Income Taxes and Available Carryforward (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	May 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Apr. 13, 2020
Operating Loss Carryforwards		$ 822,000
Effective Income Tax Rate Reconciliation, Percent, Total		25.35%	25.35%
Paycheck Protection Program CARES Act [Member]
Notes Payable, Total				$ 201,000	$ 201,000
Interest Payable, Forgiven	$ 2,172

Note K - Income Taxes and Ava_4

Note K - Income Taxes and Available Carryforward - Provision for Income Tax Expense (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Federal	$ 0	$ 0
State	0	0
Federal	21,229	(32,681)
State	4,392	(6,763)
Deferred Federal, State and Local, Tax Expense (Benefit), Total	$ 25,621	$ (39,444)

Note K - Income Taxes and Ava_5

Note K - Income Taxes and Available Carryforward - Deferred Tax Assets and Liabilities (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
NOL and contribution carryforwards	$ 208,277
Share based payments	4,988
Lease Liabilities - operating leases	164,727
Accrued compensated absences	10,604
Accrued bonus	2,734
Allowance for doubtful accounts	3,439
Deferred Tax Assets, Gross, Total	394,769
Right of use assets - operating leases	(177,981)
Excess of tax over book depreciation	(38,777)
Total deferred tax (liabilities)	(216,758)
Net deferred tax asset (liability)	178,011
Valuation Allowance	(31,960)	$ 0
Net deferred tax asset	146,051
Change in valuation allowance	$ (31,960)	$ 144,619

Note K - Income Taxes and Ava_6

Note K - Income Taxes and Available Carryforward - Income Taxes Reconciliation (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Expected benefit (provision) at US statutory rate	$ 49,436	$ (154,097)
State income tax net of federal benefit (provision)	10,229	(31,883)
Nondeductible expense	(689)	(3,450)
Non Taxable Income	0	51,494
Change in estimates of losses carryforward	(1,395)	(46,127)
Change in valuation allowance	(31,960)	144,619
Income tax benefit (expense)	$ 25,621	$ (39,444)

Note M - Major Customer (Detail

Note M - Major Customer (Details Textual)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers	1	1

Note N - Research and Develop_2

Note N - Research and Development (Details Textual) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Research and Development Expense, Total	$ 30,000	$ 30,900

Note P - Right-of-use Assets _3

Note P - Right-of-use Assets and Lease Liabilities (Details Textual) - USD ($)	1 Months Ended				12 Months Ended
	Jan. 31, 2021	Aug. 31, 2020	Feb. 28, 2018	Jun. 30, 2015	Jun. 30, 2022	Jun. 30, 2021
Variable Lease, Cost					$ 208,467	$ 133,531
Operating Lease, Weighted Average Remaining Lease Term (Year)					3 years 8 months 26 days
Operating Lease, Weighted Average Discount Rate, Percent					3.29%
Operating Lease For Office Equipment [Member]
Lessee, Operating Lease, Term of Contract (Month)				63 months
Lessee, Operating Lease, Rent Per Month				$ 1,079
Lessee, Operating Lease, Maximum Yearly Increase of Rent				3%
Lessee, Operating Lease, Discount Rate				5.50%
Operating Lease for Warehouse [Member]
Lessee, Operating Lease, Term of Contract (Month)	64 months		39 months
Lessee, Operating Lease, Maximum Yearly Increase of Rent	5%
Lessee, Operating Lease, Discount Rate	3.25%		5.50%
Lessee, Operating Lease, Rent Per Month, First Three Months			$ 0
Lessee, Operating Lease, Rent Per Month, Following 12 Months			2,936
Lessee, Operating Lease, Rent Per Month, Following 8 Months			3,024
Lessee, Operating Lease, Rent Per Month, Following 4 Months			3,019
Lessee, Operating Lease, Rent Per Month, Last 12 Months			$ 3,109
Lessee, Operating Lease, Rent Per Month, First Four Months	$ 0
Lessee, Operating Lease, Rent Per Month, Beginning 5th Month	$ 4,792.50
Lessee, Operating Lease, Minimum Yearly Increase of Rent	2%
Operating Lease for Certain Office Equipment [Member]
Lessee, Operating Lease, Term of Contract (Month)		63 months
Lessee, Operating Lease, Rent Per Month		$ 574
Lessee, Operating Lease, Discount Rate		4.25%
Operating Lease for Office Space [Member]
Lessee, Operating Lease, Term of Contract (Month)	64 months
Lessee, Operating Lease, Maximum Yearly Increase of Rent	5%
Lessee, Operating Lease, Discount Rate	3.25%
Lessee, Operating Lease, Rent Per Month, First Four Months	$ 0
Lessee, Operating Lease, Rent Per Month, Beginning 5th Month	$ 9,372
Lessee, Operating Lease, Minimum Yearly Increase of Rent	2%
Operating Lease, Initial Direct Cost Expense, over Term	$ 114,083

Note P - Right-of-use Assets _4

Note P - Right-of-use Assets and Lease Liabilities - Right-of-use Assets and Liabilities (Details) - USD ($)	73 Months Ended	85 Months Ended
	Jun. 30, 2021	Jun. 30, 2022
ROU assets - operating leases obtained in exchange for lease liabilities - operating leases		$ 973,081
Amortization of ROU assets since lease inception		(266,926)
ROU assets - operating leases at June 30, 2022	$ 882,344	706,155
Lease liabilities - operating leases on adoption date	973,081	973,081
Payments on lease liabilities	(319,222)
Lease liabilities - operating leases on June 30, 2022		653,859
Lease liabilities - operating leases due in the 12 months ending June 30, 2022	154,022	162,547
Lease liabilities - operating leases due after June 30, 2022	$ 653,860	$ 491,312